Amgen Inc (AMGN)

Add to Watchlists
Create an Alert
203.48 +2.68  +1.33% NASDAQ Oct 14, 15:08 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
10/30/2019 17:00 EDT Misc Amgen Inc Third Quarter Earnings Conference Call in 2019
10/30/2019 Earnings Amgen Inc Third Quarter Earnings in 2019 Release
08/14/2019 Dividends Amount: 1.45, Declared Date: Aug 02 2019, Pay Date: Sep 06 2019
07/30/2019 17:00 EDT Misc Amgen Inc Second Quarter Earnings Conference Call in 2019
07/30/2019 Earnings Amgen Inc Second Quarter Earnings in 2019 Release
05/21/2019 11:00 EDT Misc Amgen Inc Annual General Meeting in 2018
05/16/2019 Dividends Amount: 1.45, Declared Date: Mar 07 2019, Pay Date: Jun 07 2019
04/30/2019 17:00 EDT Misc Amgen Inc First Quarter Earnings Conference Call in 2019
04/30/2019 Earnings Amgen Inc First Quarter Earnings in 2019 Release
02/14/2019 Dividends Amount: 1.45, Declared Date: Dec 07 2018, Pay Date: Mar 08 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.amgen.com
  • Investor Relations URL: http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-IRHome
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Equity Style: Large Cap/Value
  • Next Earnings Release: Oct. 30, 2019
  • Last Earnings Release: Jul. 30, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Aug. 14, 2019
  • Description: Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and received approval for bone-strengthening drug Prolia/Xgeva in 2010. Amgen's acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine).

Top Fund Holders

Symbol Name Weighting
IBB iShares Nasdaq Biotechnology ETF 7.90%
XLV Health Care Select Sector SPDR® ETF 3.58%
VPMCX Vanguard PRIMECAP Inv 3.00%
VHT Vanguard Health Care ETF 2.85%
QUAL iShares Edge MSCI USA Quality Factor ETF 1.80%
RMEBX American Funds American Mutual R2E 1.76%
RICHX American Funds Invmt Co of Amer R5E 1.61%
QQQ Invesco QQQ Trust 1.42%
RIRHX American Funds Capital Income Bldr R5E 1.34%
AMPCX American Funds AMCAP C 1.31%
VYM Vanguard High Dividend Yield ETF 1.12%

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("AMGN","name")
  • Description: =YCI("AMGN","description")
  • Sector: =YCI("AMGN","sector")
  • Industry: =YCI("AMGN","industry")
  • Est. Current Fiscal Year End: =YCI("AMGN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.